MTOR and plasma cell myeloma: Moreover, metformin suppressed the tumor formation in the mouse model of myeloma through the overexpression of AMPK and downregulation of mTOR.359 In addition, metformin was reported to silence mTORC1 through Rag GTPases/REDD1 axis which is independent of AMPK signaling.